- Home
- Publications
- Publication Search
- Publication Details
Title
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 1, Pages 42
Publisher
MDPI AG
Online
2020-12-23
DOI
10.3390/ijms22010042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
- (2020) M. Chalabi et al. ANNALS OF ONCOLOGY
- Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer
- (2020) A. Iglesias-Santamaría Clinical & Translational Oncology
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection
- (2020) Ana Pertejo-Fernandez et al. LUNG CANCER
- Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
- (2020) Lin Shui et al. Frontiers in Immunology
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
- (2020) Huilin Xu et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- COVID-19: the use of immunotherapy in metastatic lung cancer
- (2020) Alexander P Davis et al. Immunotherapy
- NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis
- (2020) Lise Lurienne et al. Journal of Thoracic Oncology
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
- (2020) Vincenzo Di Noia et al. LUNG CANCER
- Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
- (2020) Jia Luo et al. Cancer Discovery
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection
- (2020) Maria Gonzalez-Cao et al. JAMA Oncology
- Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
- (2020) Fausto Petrelli et al. Journal of Clinical Medicine
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
- (2020) Antonio Passaro et al. ESMO Open
- 1023MO AMC 095: A report of nivolumab (nivo) in advanced HIV associated solid tumours (ST)
- (2020) L. Rajdev et al. ANNALS OF ONCOLOGY
- LBA75 Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)
- (2020) J. Baena Espinar et al. ANNALS OF ONCOLOGY
- 1389P IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced non-small cell lung cancer (NSCLC)
- (2020) A. Lavole et al. ANNALS OF ONCOLOGY
- LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
- (2020) T.M. Wise-Draper et al. ANNALS OF ONCOLOGY
- LBA52 EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%
- (2020) A. Sezer et al. ANNALS OF ONCOLOGY
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics
- (2019) F Huemer et al. ANNALS OF ONCOLOGY
- Gut microbiome and cancer immunotherapy
- (2019) Weina Li et al. CANCER LETTERS
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
- (2019) Giulia Galli et al. LUNG CANCER
- Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
- (2019) Thomas S. Uldrick et al. JAMA Oncology
- Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
- (2019) Julia Ouaknine Krief et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy for cancer in people living with HIV
- (2019) Jean-Philippe Spano et al. AIDS
- Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
- (2019) Stefania Gori et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients
- (2019) Xuan-Zhang Huang et al. OncoImmunology
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- 92O Nivolumab plus low-dose ipilimumab as first-line treatment of advanced NSCLC: Overall survival analysis of checkmate 817
- (2019) F Barlesi et al. ANNALS OF ONCOLOGY
- Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
- (2019) Giovanni Rossi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation
- (2019) Jing Jin et al. LUNG CANCER
- Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
- (2019) Carmine Carbone et al. MEDIATORS OF INFLAMMATION
- The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
- (2019) Brooke E. Wilson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review
- (2019) Misako Nagasaka et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
- (2019) Neil J. Shah et al. Journal for ImmunoTherapy of Cancer
- PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?
- (2018) A Lavolé et al. ANNALS OF ONCOLOGY
- Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection
- (2018) Giuseppe Luigi Banna et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells
- (2018) Filippos Porichis et al. JOURNAL OF IMMUNOLOGY
- Current antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses
- (2018) Lucie Nováková et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non–Small Cell Lung Cancer
- (2018) Lorena Ostios-Garcia et al. Journal of Thoracic Oncology
- Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis
- (2018) Anita Kothapalli et al. MELANOMA RESEARCH
- HIV-Associated Cancers and Related Diseases
- (2018) Robert Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
- (2018) Lisa Derosa et al. OncoImmunology
- Impact of anti-infectious and corticosteroids on immunotherapy: Nivolumab and pembrozilumab follow-up in a French study.
- (2018) Jean-Philippe Metges et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade
- (2018) Natalie Galanina et al. Cancer Immunology Research
- Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
- (2018) S Sen et al. ANNALS OF ONCOLOGY
- Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection
- (2018) Martin Tio et al. EUROPEAN JOURNAL OF CANCER
- Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer
- (2018) Arsela Prelaj et al. EUROPEAN JOURNAL OF CANCER
- Recovery of gut microbiota of healthy adults following antibiotic exposure
- (2018) Albert Palleja et al. Nature Microbiology
- Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study
- (2018) Rosário Serrão et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group
- (2017) Thomas S. Uldrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic obstructive pulmonary disease
- (2017) Klaus F Rabe et al. LANCET
- IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth
- (2017) C Jungnickel et al. ONCOGENE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States
- (2017) Krishna P. Reddy et al. JAMA Internal Medicine
- Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer
- (2017) Brennan McCullar et al. Journal of Thoracic Disease
- Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States
- (2015) Rennatus Mdodo et al. ANNALS OF INTERNAL MEDICINE
- Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
- (2015) Ben Boursi et al. EUROPEAN JOURNAL OF CANCER
- Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
- (2015) Vijayakumar Velu et al. Retrovirology
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000
- (2015) Marie-Anne Vandenhende et al. PLoS One
- Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
- (2014) R. Mahajan et al. CLINICAL INFECTIOUS DISEASES
- Gastrointestinal Malignancy and the Microbiome
- (2014) Maria T. Abreu et al. GASTROENTEROLOGY
- The role of the microbiome in exacerbations of chronic lung diseases
- (2014) Robert P Dickson et al. LANCET
- T helper 17 cells play a critical pathogenic role in lung cancer
- (2014) S. H. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis
- (2014) Robert P Dickson et al. Lancet Respiratory Medicine
- HIV as an independent risk factor for incident lung cancer
- (2012) Keith Sigel et al. AIDS
- Cancer Burden in the HIV-Infected Population in the United States
- (2011) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Incidence et caractéristiques des colonisations des voies respiratoires lors du diagnostic de cancer bronchique : étude rétrospective de 388 cas
- (2011) S. Laroumagne et al. REVUE DES MALADIES RESPIRATOIRES
- Identification of PD-1 as a Unique Marker for Failing Immune Reconstitution in HIV-1–Infected Patients on Treatment
- (2010) Katharina Grabmeier-Pfistershammer et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-term impacts of antibiotic exposure on the human intestinal microbiota
- (2010) C. Jernberg et al. MICROBIOLOGY-SGM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search